Related Experiment Video
Updated: Aug 8, 2026
14:21
Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking
Published on: August 6, 2013
[Benzodiazepine receptor imaging in the brain: recent developments and clinical validity]
1Department of Neuropsychiatry, Faculty of Medicine, Kagawa Medical University.
Kaku Igaku. the Japanese Journal of Nuclear Medicine
|July 3, 1999
Summary
Benzodiazepine receptor imaging shows decreased binding in epilepsy foci and abnormal patterns in panic disorder. These findings support its clinical validity for diagnosing epilepsy and understanding panic disorder mechanisms.
Area of Science:
- Neuroscience
- Radiology
- Psychiatry
Background:
- Benzodiazepine receptor imaging techniques like 123I-Iomazenil SPECT and 11C-Flumazenil PET have advanced.
- These imaging modalities are increasingly used to study neuropsychiatric disorders.
Purpose of the Study:
- To review recent developments in benzodiazepine receptor imaging for neuropsychiatric disorders.
- To assess the clinical validity and potential mechanisms of benzodiazepine receptor imaging in focal epilepsy and panic disorder.
Main Methods:
- Review of previous studies utilizing 123I-Iomazenil SPECT and 11C-Flumazenil PET.
- Comparison of benzodiazepine receptor imaging with regional cerebral blood flow imaging in epilepsy.
Main Results:
- Benzodiazepine receptor imaging demonstrated decreased binding in epileptic foci, showing higher sensitivity than cerebral blood flow imaging for medial temporal lobe epilepsy.
- Abnormal benzodiazepine receptor binding was observed in the temporal, parietal, and frontal cortex in patients with panic disorder.
Conclusions:
- Benzodiazepine receptor imaging is clinically valid for focal epilepsy, potentially linked to GABA/benzodiazepine system disinhibition.
- Further research is needed to elucidate the "benzodiazepine dysfunction hypothesis" in panic disorder using these imaging techniques.
More Related Videos
Related Concept Videos
01:29Positron Emission Tomography
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
01:14Brain Imaging
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).